CenterBook Partners LP

Position in XERS — Xeris Biopharma Holdings, Inc.

CIK 1872738 GREENWICH, CT

Position in XERS

as of Mar 31, 2026 · filed May 5, 2026 Compact

Position Value

$7,242,001

-$3,681,980 QoQ

Shares Held

1,248,621

-10.3% QoQ

Ownership

0.723%

of shares outstanding

% of Portfolio

0.39%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2023

10 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Mar 31, 2026

CenterBook Partners LP holds $15,544,705 across 5 Drug Manufacturers - Specialty & Generic names. XERS ranks #1 (46.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	XERS	Xeris Biopharma Holdings, Inc. This page	1,248,621	$7,242,001
2	LQDA	Liquidia Corp	114,909	$4,336,665
3	INDV	Indivior Pharmaceuticals, Inc.	48,502	$1,478,340
4	ALKS	Alkermes plc.	38,625	$1,365,780
5	RDY	Dr Reddys Laboratories Ltd	81,005	$1,121,919

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$7,242,001	1,248,621	-10.3%	Shares	Sole	2026-05-05
2025-12-31	$10,923,981	1,391,590	+99.3%	Shares	Sole	2026-02-11
2025-09-30	$5,683,380	698,204	-56.2%	Shares	Sole	2025-11-07
2025-06-30	$7,445,049	1,594,229	+237.7%	Shares	Sole	2025-08-12
2025-03-31	$2,591,691	472,075	-31.6%	Shares	Sole	2025-05-09
2024-12-31	$2,339,361	690,077	-80.2%	Shares	Sole	2025-02-13
2024-09-30	$9,923,717	3,482,006	+137.5%	Shares	Sole	2024-11-14
2024-06-30	$3,298,218	1,465,875	-5.1%	Shares	Sole	2024-08-12
2024-03-31	$3,411,959	1,543,873	+1295.6%	Shares	Sole	2024-05-10
2023-12-31	$259,973	110,627	—	Shares	Sole	2024-02-13
No filing history on record for this holder in this stock.